Sugar-sweetened drinks linked to 1 in 10 new diabetes cases

The consumption of sugar-sweetened beverages is driving millions of diabetes and heart disease cases worldwide, with significant regional health inequalities.

Rucaparib camsylate by Pharmaand for Pancreatic Ductal Adenocarcinoma: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

May 20, 2024

More Intense ALL Therapy Improves Outcomes in Adolescents, Young Adults

HOUSTON — Pediatric treatment protocols outperformed standard therapy for adolescents and young adults (AYAs) with Philadelphia chromosome-negative acute lymphocytic leukemia (ALL), a retrospective cohort study

September 8, 2023

FDA approves BeiGene’s TEVIMBRA for oesophageal cancer

Share this article BeiGene’s TEVIMBRA is indicated to treat adults with unresectable or metastatic oesophageal squamous cell carcinoma. Credit: Kateryna Kon / Shutterstock.com. The US

March 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.